Matches in SemOpenAlex for { <https://semopenalex.org/work/W2887438949> ?p ?o ?g. }
- W2887438949 endingPage "68" @default.
- W2887438949 startingPage "60" @default.
- W2887438949 abstract "This article reviews the 6-month followup data of a randomized, multicenter, parallel-group study conducted at five clinical sites in three European cities, which compared two second-level treatments for bulimia nervosa (BN) and binge eating disorder (BED): virtual reality-based cue exposure therapy (VR-CET) versus additional cognitive behavioral therapy (A-CBT). Post-treatment outcomes of this study were previously published and details of its design can be found at clinicaltrials.gov (identifier: NCT02237300). This article focuses on the evolution of symptoms assessed after 6 months of followup in a subgroup of 58 patients from the original study. In this study 64 patients with eating disorders (EDs) (35 with BN and 29 with BED), who still showed active episodes of binge eating by the end of a structured CBT program (first-level treatment), were randomly assigned to one of two second-level treatments (A-CBT or VR-CET). Frequency of binge and purge episodes, and attitudinal features of binge-related EDs (bulimia, drive for thinness, and body dissatisfaction) were assessed before starting the second-level treatment (n = 64), at the end (n = 64), and at 6-month followup (n = 58). Mixed between-within subject analyses of variance were used to compare outcomes of both second-level treatments over time. Although both treatment conditions showed statistically significant improvements at the end and after 6-month followup, obtained reductions were greater after VR-CET, regarding binge and purge episodes, as well as the decrease of self-reported tendency to engage in overeating episodes. Accordingly, abstinence from binge episodes were higher in VR-CET than A-CBT at followup (70 percent vs. 26 percent, respectively; χ2 = 11.711, p = 0.001). These results provide further support for the use of VR-CET as an effective second-level intervention for BN and BED treatment-resistant patients." @default.
- W2887438949 created "2018-08-22" @default.
- W2887438949 creator A5003496200 @default.
- W2887438949 creator A5005072522 @default.
- W2887438949 creator A5006311128 @default.
- W2887438949 creator A5009168237 @default.
- W2887438949 creator A5012008760 @default.
- W2887438949 creator A5023475881 @default.
- W2887438949 creator A5030480720 @default.
- W2887438949 creator A5034408869 @default.
- W2887438949 creator A5039928923 @default.
- W2887438949 creator A5040591643 @default.
- W2887438949 creator A5042143564 @default.
- W2887438949 creator A5043804253 @default.
- W2887438949 creator A5044656876 @default.
- W2887438949 creator A5048245787 @default.
- W2887438949 creator A5055308138 @default.
- W2887438949 creator A5065621192 @default.
- W2887438949 date "2019-01-01" @default.
- W2887438949 modified "2023-10-17" @default.
- W2887438949 title "A Randomized Trial of Virtual Reality-Based Cue Exposure Second-Level Therapy and Cognitive Behavior Second-Level Therapy for Bulimia Nervosa and Binge-Eating Disorder: Outcome at Six-Month Followup" @default.
- W2887438949 cites W1966809436 @default.
- W2887438949 cites W1968168083 @default.
- W2887438949 cites W1972883514 @default.
- W2887438949 cites W1978809051 @default.
- W2887438949 cites W1983650731 @default.
- W2887438949 cites W1984576503 @default.
- W2887438949 cites W2002077172 @default.
- W2887438949 cites W2003072869 @default.
- W2887438949 cites W2012404877 @default.
- W2887438949 cites W2014528708 @default.
- W2887438949 cites W2021487445 @default.
- W2887438949 cites W2029484301 @default.
- W2887438949 cites W2036076263 @default.
- W2887438949 cites W2057992219 @default.
- W2887438949 cites W2078464977 @default.
- W2887438949 cites W2081429858 @default.
- W2887438949 cites W2084065714 @default.
- W2887438949 cites W2105558311 @default.
- W2887438949 cites W2105936789 @default.
- W2887438949 cites W2107026277 @default.
- W2887438949 cites W2118666655 @default.
- W2887438949 cites W2126880703 @default.
- W2887438949 cites W2127875809 @default.
- W2887438949 cites W2129360943 @default.
- W2887438949 cites W2143116894 @default.
- W2887438949 cites W2146052050 @default.
- W2887438949 cites W2149539880 @default.
- W2887438949 cites W2154420397 @default.
- W2887438949 cites W2159682265 @default.
- W2887438949 cites W2159932915 @default.
- W2887438949 cites W2165095105 @default.
- W2887438949 cites W2167217873 @default.
- W2887438949 cites W2177015639 @default.
- W2887438949 cites W2197231363 @default.
- W2887438949 cites W2503720122 @default.
- W2887438949 cites W2555741147 @default.
- W2887438949 cites W2560462001 @default.
- W2887438949 cites W2593537804 @default.
- W2887438949 cites W2610544237 @default.
- W2887438949 cites W2620688670 @default.
- W2887438949 cites W2743123733 @default.
- W2887438949 cites W2747137660 @default.
- W2887438949 cites W2753452070 @default.
- W2887438949 cites W2763378077 @default.
- W2887438949 cites W2766522475 @default.
- W2887438949 cites W2766766803 @default.
- W2887438949 cites W2778044155 @default.
- W2887438949 cites W2786304541 @default.
- W2887438949 cites W2807748013 @default.
- W2887438949 cites W4247665917 @default.
- W2887438949 doi "https://doi.org/10.1089/cyber.2017.0675" @default.
- W2887438949 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30059240" @default.
- W2887438949 hasPublicationYear "2019" @default.
- W2887438949 type Work @default.
- W2887438949 sameAs 2887438949 @default.
- W2887438949 citedByCount "48" @default.
- W2887438949 countsByYear W28874389492019 @default.
- W2887438949 countsByYear W28874389492020 @default.
- W2887438949 countsByYear W28874389492021 @default.
- W2887438949 countsByYear W28874389492022 @default.
- W2887438949 countsByYear W28874389492023 @default.
- W2887438949 crossrefType "journal-article" @default.
- W2887438949 hasAuthorship W2887438949A5003496200 @default.
- W2887438949 hasAuthorship W2887438949A5005072522 @default.
- W2887438949 hasAuthorship W2887438949A5006311128 @default.
- W2887438949 hasAuthorship W2887438949A5009168237 @default.
- W2887438949 hasAuthorship W2887438949A5012008760 @default.
- W2887438949 hasAuthorship W2887438949A5023475881 @default.
- W2887438949 hasAuthorship W2887438949A5030480720 @default.
- W2887438949 hasAuthorship W2887438949A5034408869 @default.
- W2887438949 hasAuthorship W2887438949A5039928923 @default.
- W2887438949 hasAuthorship W2887438949A5040591643 @default.
- W2887438949 hasAuthorship W2887438949A5042143564 @default.
- W2887438949 hasAuthorship W2887438949A5043804253 @default.
- W2887438949 hasAuthorship W2887438949A5044656876 @default.
- W2887438949 hasAuthorship W2887438949A5048245787 @default.
- W2887438949 hasAuthorship W2887438949A5055308138 @default.